Stocklytics Platform

Income Statement

publish
The Stocklytics Income Statement Screener empowers investors to focus on companies with strong financial fundamentals. Whether you’re interested in growth, profitability, or overall revenue strength, this tool helps you make informed decisions.
name
arrow_downwardRevenue Price $ Change % Change Revenue Growth % Gross Profit Operating Income Net Income EBITDA EPS Diluted
GIPR
GIPRWGeneration Income Properties
_$0.10$0.100.00%arrow_drop_up40.49%$5.93M-$3.45M-$5.71M$3.39M-3.39
PGYW
PGYWWPagaya Technologies Ltd.
_$0.16-$0.00arrow_drop_down1.38%arrow_drop_up12.75%$263.87M-$24.40M-$128.43M$41.47M0.00
Asset logo for symbol CELUW
CELUWCelularity
_$0.04-$0.01arrow_drop_down19.33%-$6.75M-$192.28M-$196.29M-$31.58M-0.87
FCRX
FCRXFirst Eagle Alternative Capital
_$24.81-$0.02arrow_drop_down0.10%arrow_drop_up51.30%$147.53M$142.59M$83.83M$0.000.14
Asset logo for symbol LAC
LACLithium Americas
_$2.83$0.01arrow_drop_up0.35%-_-$27.62M-$3.93M-$31.23M-0.12
Asset logo for symbol THM
THMInternational Tower Hill Mines Ltd
_$0.85$0.04arrow_drop_up4.91%-_-$3.28M-$3.39M$0.00-0.02
Asset logo for symbol VERA
VERAVera Therapeutics
_$19.65-$0.18arrow_drop_down0.94%-_-$167.17M-$152.14M-$167.10M-2.75
Asset logo for symbol SLI
SLIStandard Lithium Ltd.
_$1.74$0.15arrow_drop_up9.56%-_-$45.41M$107.65M-$30.29M0.61
REX
REXREX American Resources
_$41.62-$0.02arrow_drop_down0.04%-$98.21M$68.83M$60.93M$98.48M3.82
Asset logo for symbol CVKD
CVKDCadrenal Therapeutics
_$14.75-$0.28arrow_drop_down1.86%-_-$7.63M-$8.35M-$7.94M-6.73
Asset logo for symbol DXYN
DXYNDixie Group
_$0.64-$0.15arrow_drop_down18.98%-$73.87M$5.04M-$1.95M$7.90M-0.14
Asset logo for symbol MEOH
MEOHMethanex
_$32.80$0.09arrow_drop_up0.27%-$655.40M$263.57M$284.12M$764.00M2.39
Asset logo for symbol THCH
THCHTH International Limited
_$2.79$0.29arrow_drop_up11.50%arrow_drop_up55.85%$417.15M-$701.18M-$872.92M-$24.30M-2.80
Asset logo for symbol CAKE
CAKECheesecake Factory
_$52.81$0.47arrow_drop_up0.89%arrow_drop_up4.13%$2.77B$178.31M$156.78M$326.17M3.20
Asset logo for symbol TCBP
TCBPTC Biopharm
_$1.65$0.02arrow_drop_up1.22%-_-$14.23M-$5.90M-$14.24M-192.95
Asset logo for symbol PUMP
PUMPProPetro Holding
_$5.52-$0.04arrow_drop_down0.80%-$644.08M$529.76M-$137.85M$269.97M-1.31
Asset logo for symbol RGS
RGSRegis
_$23.59$1.42arrow_drop_up6.36%-$101.76M$20.89M$91.06M$21.19M36.74
JCSE
JCSEJE Cleantech Holdings Limited
_$1.27$0.09arrow_drop_up8.08%-$4.36M$1.01M$519.00K$2.11M0.12
GGRO
GGROWGogoro
_$0.01-$0.00arrow_drop_down8.48%-$50.93M-$88.37M-$76.03M$33.90M0.00
Asset logo for symbol HOTH
HOTHHoth Therapeutics
_$0.85$0.01arrow_drop_up2.35%-_-$7.69M-$7.84M$0.00-1.27
Showing 4741-4760 of 4978
Results per page:

Gain deeper insights into a company's earnings with the Stocklytics Income Statement Screener, designed to rank stocks in descending order of revenue. This tool allows you to quickly assess companies with the highest revenue and their overall income performance, providing key financial metrics for smarter investment decisions. Our screener offers detailed insights into the following income statement components: - Revenue Growth – Identify companies with impressive year-over-year growth, a critical indicator of potential future success. - Gross Profit – Analyze how well a company is managing its core production costs to generate profit. - Operating Income – Understand a company’s ability to generate profit from its primary operations, excluding non-operational activities. - Net Income – Examine the company's bottom line after all expenses, providing a clear picture of profitability. - EBITDA – Evaluate a company’s earnings before interest, taxes, depreciation, and amortization to get a sense of its overall profitability and operating performance. - EPS Diluted – Review earnings per share on a diluted basis, reflecting potential impacts of convertible securities and giving you a clearer picture of shareholder returns. By using the Stocklytics Income Statement Screener, you’ll have access to vital financial data that will help you evaluate a company's performance, profitability, and growth potential. Why the Income Statement Matters: - Revenue Performance: Understand which companies are excelling at generating top-line revenue. - Profitability: Analyze margins and earnings to identify financially strong companies. - Earnings Per Share: Evaluate companies with high earnings per share, a key metric for investors.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Take Your Investments to a Whole New Level